Answer
The most common adverse reaction to remdesivir in patients with COVID-19 is nausea, reported in 4% of patients.
Sources for this answer
- Veklury 100 mg powder for concentrate for solution for infusionGilead Sciences Ltd · emc · SmPC §4.8 Undesirable effects · Version 26Document updated
Sources checked